gsk1144814
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00513565)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Neurokinin 3 receptorANTAGONIST
TACR3 antagonist
- Neurokinin 1 receptorANTAGONIST
TACR1 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsk1144814
- gsk114814
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01181908 | Phase 1 | Nov 11, 2009 | GlaxoSmithKline |
| NCT01090440 | Phase 1 | Sep 1, 2009 | GlaxoSmithKline |
| NCT01209039 | Phase 1 | Jul 1, 2009 | GlaxoSmithKline |
| NCT01381419 | Phase 1 | Oct 1, 2008 | GlaxoSmithKline |
| NCT00513565 | Phase 1 | Sep 1, 2007 | GlaxoSmithKline |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 5 | 5 | 1 | 2007 |
1 organizations
Page 1 / 1